article thumbnail

European Society of Cardiology Core Curriculum for cardio?oncology

European Journal of Heart Failure

Abstract Cardio-oncology is a rapidly growing field of cardiovascular (CV) medicine that has resulted from the continuously increasing clinical demand for specialized CV evaluation, prevention and management of patients suffering or surviving from malignant diseases.

article thumbnail

Study Finds Air Pollution Can Increase Cardiovascular Risk for Cancer Patients

DAIC

Getty Images milla1cf Wed, 06/19/2024 - 20:54 June 19, 2024 — Modern therapies have extended the lives of many cancer patients; however, survivors often live with chronic health conditions, including cardiovascular disease. The new study was motivated by a need to fill that gap, Rao said. They found that exposure to PM2.5,

article thumbnail

JACC: CardioOncology Expert Panel Addresses Cardiotoxicity During Cancer Therapy

American College of Cardiology

Preventing, detecting and managing cancer therapy-related cardiovascular toxicity (CTR-CVT) is a clear objective during cancer treatment.

article thumbnail

Heart-related side effects of cancer treatment must be addressed as early as possible, experts say

Medical Xpress - Cardiology

The devastating news of a cancer diagnosis understandably makes doctors and patients focus on the cancer itself.

article thumbnail

Long-term Survivors of Childhood Cancer at Higher Risk of Death Following Heart Issues; Threshold for Treating Risk Factors Should be Lower

DAIC

The findings – published this week in the Journal of the American College of Cardiology — could fuel advocacy for a paradigm shift in clinical heart health guidelines to address cardiovascular risk factors at an earlier age in childhood cancer survivors. “We Wendy Bottinor, MD.

article thumbnail

Navigating P2Y12 inhibition in the labyrinth of cardio-oncology care: cangrelor bridging in patients with cancer

Frontiers in Cardiovascular Medicine

This is the first case series to shed light on the application of cangrelor in cancer patients needing to pause dual antiplatelet therapy for a range of medical interventions, marking it as a pioneering effort in this domain.

article thumbnail

Artificial Intelligence to Enhance Precision Medicine in Cardio-Oncology: A Scientific Statement From the American Heart Association

Circulation: Genomic and Precision Medicine

Artificial intelligence is poised to transform cardio-oncology by enabling personalized care for patients with cancer, who are at a heightened risk of cardiovascular disease due to both the disease and its treatments.